MedTrace Logo

Calibration Study of a Blood Alcohol Level Smart Watch

NCT03574181 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2021-02-18

Study results available
· View outcomes & findings →

Summary

This trial is designed to test the accuracy of a wristwatch blood alcohol level monitor relative to alcohol breath testing. An established human laboratory self-administration procedure will be followed. Each subject will complete 2 clinic visits over a period of up to 21 days of participation. Study participation is comprised of a baseline assessment to determine eligibility and an alcohol self-administration trial to test the accuracy of the wrist watch blood alcohol level. Subjects will be recruited in two phases of 9 subjects each. The first phase will be conducted to validate a prototype of the wrist watch. The second phase will be conducted to validate a pre-production consumer model of the blood alcohol wrist watch.

Conditions

  • Alcohol Drinking

Interventions

OTHER

Smartwatch to measure Blood Alcohol Level (BAL)

Subjects will wear a wristwatch with a sensor that measures blood alcohol level during a 1-hour period of consuming alcohol followed by a 5 hour observation period.

Sponsors & Collaborators

  • KWJ Engineering

    collaborator INDUSTRY

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Eric Devine, PhD · Boston Medical Center

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-08
Primary Completion
2020-02-17
Completion
2020-02-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03574181 on ClinicalTrials.gov